[The effect of an infection due to the hepatitis B virus on the treatment results in breast cancer patients with bone metastases].
The study deals with the influence of persistent hepatitis B virus infection on immediate and end results of chemotherapy for breast cancer with bony metastases. The infection was shown to be associated with lower complete and partial remission rates, lower 3-year survival rate and higher rate of combination chemotherapy toxic effects such as nausea, vomiting and increased activity of aminotransferases.
Zeĭnalov
R S
RS
Mamedov
M K
MK
Faradzhev
O F
OF
D001859:Bone Neoplasms / Q000276:immunology / Q000401:mortality / Q000556:secondary* / Q000628:therapy*; D001943:Breast Neoplasms / Q000276:immunology / Q000401:mortality / Q000628:therapy*; D003131:Combined Modality Therapy; D005260:Female; D006509:Hepatitis B / Q000150:complications* / Q000276:immunology / Q000401:mortality; D006510:Hepatitis B Antibodies / Q000097:blood; D006512:Hepatitis B Core Antigens / Q000276:immunology; D006514:Hepatitis B Surface Antigens / Q000097:blood; D006801:Humans; D011379:Prognosis; D012074:Remission Induction
D006510:Hepatitis B Antibodies; D006512:Hepatitis B Core Antigens; D006514:Hepatitis B Surface Antigens
Vliianie infektsii, obuslovlennoĭ virusom gepatita B, na rezul'taty lecheniia bol'nykh rakom molochnoĭ zhelezy s metastazami v kosti.